Authors: Kampman, KM Alterman, AI Volpicelli, JR Maany, I Muller, ES Luce, DD Mulholland, EM Jawad, AF Parikh, GA Mulvaney, FD Weinrieb, RM O'Brien, CP

Citation: Km. Kampman et al., Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment, PSYCH ADDIC, 15(1), 2001, pp. 52-59

Authors: Kampman, KM Volpicelli, JR Mulvaney, F Alterman, AI Cornish, J Gariti, P Cnaan, A Poole, S Muller, E Acosta, T Luce, D O'Brien, C

Citation: Km. Kampman et al., Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity, DRUG AL DEP, 63(1), 2001, pp. 69-78

Authors: Kampman, KM Rukstalis, M Pettinati, H Muller, E Acosta, T Gariti, P Ehrman, R O'Brien, CP

Citation: Km. Kampman et al., The combination of phentermine and fenfluramine reduced cocaine withdrawalsymptoms in an open trial, J SUBST ABU, 19(1), 2000, pp. 77-79

Authors: Kampman, KM Volpicelli, JR Alterman, AI Cornish, J O'Brien, CP

Citation: Km. Kampman et al., Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms, AM J PSYCHI, 157(12), 2000, pp. 2052-2054

Authors: Oslin, DW Pettinati, HM Volpicelli, JR Wolf, AL Kampman, KM O'Brien, CP

Citation: Dw. Oslin et al., The effects of naltrexone on alcohol and cocaine use in dually addicted patients, J SUBST ABU, 16(2), 1999, pp. 163-167

Authors: Kampman, KM Rukstalis, M Ehrman, R McGinnis, DE Gariti, P Volpicelli, JR Pettinati, H O'Brien, CP

Citation: Km. Kampman et al., Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence, ADDICT BEHA, 24(2), 1999, pp. 287-291